Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more
Market Cap & Net Worth: Sunzen Biotech Bhd (0148)
Sunzen Biotech Bhd (KLSE:0148) has a market capitalization of $43.39 Million (RM195.41 Million) as of March 19, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #27356 globally and #449 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sunzen Biotech Bhd's stock price RM0.25 by its total outstanding shares 781638353 (781.64 Million).
Sunzen Biotech Bhd Market Cap History: 2015 to 2026
Sunzen Biotech Bhd's market capitalization history from 2015 to 2026. Data shows change from $62.41 Million to $43.39 Million (-3.21% CAGR).
Sunzen Biotech Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sunzen Biotech Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.61x
Sunzen Biotech Bhd's market cap is 0.61 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
10.54x
Sunzen Biotech Bhd's market cap is 10.54 times its annual earnings
5.50x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $35.19 Million | $40.01 Million | -$130.07K | 0.88x | N/A |
| 2017 | $53.80 Million | $303.45 Million | $3.47 Million | 0.18x | 15.49x |
| 2018 | $28.63 Million | $296.16 Million | -$6.94 Million | 0.10x | N/A |
| 2019 | $18.22 Million | $240.58 Million | -$16.25 Million | 0.08x | N/A |
| 2020 | $31.24 Million | $82.23 Million | -$13.23 Million | 0.38x | N/A |
| 2021 | $43.39 Million | $90.48 Million | $680.14K | 0.48x | 63.79x |
| 2022 | $34.71 Million | $97.09 Million | $3.75 Million | 0.36x | 9.26x |
| 2023 | $52.06 Million | $85.82 Million | $4.94 Million | 0.61x | 10.54x |
Competitor Companies of 0148 by Market Capitalization
Companies near Sunzen Biotech Bhd in the global market cap rankings as of March 19, 2026.
Key companies related to Sunzen Biotech Bhd by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #55 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #68 globally with a market cap of $226.90 Billion USD ( CHF207.77 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #437 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #458 globally with a market cap of $47.46 Billion USD ( €46.23 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #55 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #68 | Nestlé S.A. | SW:NESN | $226.90 Billion | CHF80.84 |
| #437 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #458 | Danone SA | PA:BN | $47.46 Billion | €73.12 |
Sunzen Biotech Bhd Historical Marketcap From 2015 to 2026
Between 2015 and today, Sunzen Biotech Bhd's market cap moved from $62.41 Million to $ 43.39 Million, with a yearly change of -3.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM43.39 Million | -5.66% |
| 2025 | RM45.99 Million | -18.46% |
| 2024 | RM56.40 Million | +8.33% |
| 2023 | RM52.06 Million | +50.00% |
| 2022 | RM34.71 Million | -20.00% |
| 2021 | RM43.39 Million | +38.89% |
| 2020 | RM31.24 Million | +71.43% |
| 2019 | RM18.22 Million | -36.36% |
| 2018 | RM28.63 Million | -46.77% |
| 2017 | RM53.80 Million | +52.86% |
| 2016 | RM35.19 Million | -43.60% |
| 2015 | RM62.41 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sunzen Biotech Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.39 Million USD |
| MoneyControl | $43.39 Million USD |
| MarketWatch | $43.39 Million USD |
| marketcap.company | $43.39 Million USD |
| Reuters | $43.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.